CHILDREN'S HOSPITAL OF PHILADELPHIA
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1855-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.chop.edu/
Vibrating, Cold Device for Pediatric Intravenous (IV) Cannulation Pain Relief
Phase 2
Completed
- Conditions
- PainAnxiety
- Interventions
- Device: BuzzyDrug: Topical Lidocaine 4% Cream
- First Posted Date
- 2011-07-14
- Last Posted Date
- 2016-09-16
- Lead Sponsor
- Children's Hospital of Philadelphia
- Target Recruit Count
- 240
- Registration Number
- NCT01394250
- Locations
- 🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Differences Between the Bayley-II and the Bayley-III in Very Preterm Infants at 2 Years
Not Applicable
Completed
- Conditions
- Infant Development
- Interventions
- Diagnostic Test: Bayley Scales of Infant Development-IIDiagnostic Test: Bayley Scales of Infant Development-III
- First Posted Date
- 2011-06-14
- Last Posted Date
- 2019-11-21
- Lead Sponsor
- Children's Hospital of Philadelphia
- Target Recruit Count
- 119
- Registration Number
- NCT01373177
- Locations
- 🇺🇸
The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
More Frequent In-Center Hemodialysis in Pediatric End Stage Renal Disease
Not Applicable
Completed
- Conditions
- HemodialysisPediatric End Stage Renal Disease
- Interventions
- Procedure: Hemodialysis
- First Posted Date
- 2011-05-11
- Last Posted Date
- 2013-12-31
- Lead Sponsor
- Children's Hospital of Philadelphia
- Target Recruit Count
- 7
- Registration Number
- NCT01352455
- Locations
- 🇺🇸
Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio, United States
🇺🇸Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇨🇦The Hospital for Sick Children, Toronto, Canada
Increasing Ureagenesis in Inborn Errors of Metabolism With N-Carbamylglutamate
Phase 2
Withdrawn
- Conditions
- Urea Cycle Disorders, InbornCarbamyl Phosphate Synthetase DeficiencyInborn Errors of MetabolismPropionic AcidemiaMethylmalonic Acidemia
- Interventions
- First Posted Date
- 2011-04-25
- Last Posted Date
- 2014-05-29
- Lead Sponsor
- Children's Hospital of Philadelphia
- Registration Number
- NCT01341379
Neonatal Non-Invasive Hemoglobin Determination
Withdrawn
- Conditions
- Surgical ProceduresInfant, NewbornInfant, Low Birth Weight
- First Posted Date
- 2011-04-15
- Last Posted Date
- 2013-01-08
- Lead Sponsor
- Children's Hospital of Philadelphia
- Registration Number
- NCT01335919
Spine Quantitative Computed Tomography (QCT) for the Assessment of Osteoporosis on Children
Completed
- Conditions
- Systemic Lupus Erythematosus
- First Posted Date
- 2011-04-06
- Last Posted Date
- 2017-10-03
- Lead Sponsor
- Children's Hospital of Philadelphia
- Target Recruit Count
- 32
- Registration Number
- NCT01330368
- Locations
- 🇺🇸
The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
A New Nasopharyngeal pH Probe for Diagnosis of Laryngopharyngeal Reflux
Phase 4
Withdrawn
- Conditions
- Laryngopharyngeal Reflux
- Interventions
- Device: Dx-pH probe
- First Posted Date
- 2011-03-04
- Last Posted Date
- 2012-03-30
- Lead Sponsor
- Children's Hospital of Philadelphia
- Registration Number
- NCT01308502
- Locations
- 🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Improving Primary Care Follow-up for Patients With Pelvic Inflammatory Disease
Not Applicable
Completed
- Conditions
- Pelvic Inflammatory Disease
- Interventions
- Behavioral: Text Message Reminders
- First Posted Date
- 2011-02-18
- Last Posted Date
- 2014-10-28
- Lead Sponsor
- Children's Hospital of Philadelphia
- Target Recruit Count
- 95
- Registration Number
- NCT01299259
- Locations
- 🇺🇸
The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Compassionate Use of Omegaven for Pediatric Patients With Parenteral Nutrition Associated Liver Disease
- Conditions
- Short Bowel SyndromeCholestasis
- First Posted Date
- 2011-02-17
- Last Posted Date
- 2019-04-12
- Lead Sponsor
- Children's Hospital of Philadelphia
- Registration Number
- NCT01297933
- Locations
- 🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
IV Glucose for Dehydration Treatment
Phase 2
Completed
- Conditions
- Dehydration
- Interventions
- Drug: 5% Dextrose (D5) in Normal Saline (NS)Drug: Normal Saline (NS)
- First Posted Date
- 2011-01-28
- Last Posted Date
- 2019-03-19
- Lead Sponsor
- Children's Hospital of Philadelphia
- Target Recruit Count
- 83
- Registration Number
- NCT01285713
- Locations
- 🇺🇸
The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
© Copyright 2025. All Rights Reserved by MedPath